Skin care and oral care in the plus for J&J's second quarter

By Pooja Kondhia

- Last updated on GMT

Related tags Percent William c. weldon Johnson & johnson

US-based personal care products giant Johnson and Johnson has released its second quarter results for this year 2011, with skin care and oral care both in the plus.

Johnson and Johnson’s results for the second quarter have shown an increase in sales from the second quarter of the previous year 2010, of 8.3 percent to $16.6 billion.

In addition, operational results for the quarter increased by 2.6 percent. Domestic sales only rose by 0.01 percent, however international sales rose by 15.9 percent, which reflected operational growth of 4.9 percent.

Consumer sales

Worldwide consumer sales of 3.8 billion showed an increase of 4 percent for the second quarter as opposed to the previous year, which consisted of an operational decline of 1.8 percent.

Domestic sales decreased 8.5 percent whereas international sales rose 12.4 percent pointing towards an operational increase of 2.8 percent.

Oral and skin care sales were strong with increases of 6.8 percent and 6.4 percent respectively, in comparison to the previous year 2010; oral care sales came in at $158 million whereas skin care came in at $449 million.

First quarter

For the first quarter of 2011, sales of $16.2 billion were achieved; it was unveiled by Johnson and Johnson, which was an increase of 3.5% as compared to the first quarter of 2010.

Worldwide consumer sales of $3.7 billion for the first quarter represented a decrease of 2.2 percent in comparison to the prior year, which consisted of an operational decline of 4.1 percent.

Domestic sales decreased 13.8 percent; however, international sales increased 5.9%, which reflected an operational increase of 2.6 percent.

"The innovations we are bringing to the market, the changes we are implementing in manufacturing and quality, and the dedication of the people of Johnson & Johnson, give us great confidence in the future growth prospects of our business,"​ commented William C. Weldon, CEO of Johnson and Johnson.

Related topics Business & Financial

Related news

Show more